All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Hepatic arterial infusion in hepatocellular carcinoma: a single center experience.

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F15%3A33150533" target="_blank" >RIV/61989592:15110/15:33150533 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216208:11150/15:10319149 RIV/00179906:_____/15:10319149

  • Result on the web

    <a href="http://dx.doi.org/10.5507/bp.2014.054" target="_blank" >http://dx.doi.org/10.5507/bp.2014.054</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.5507/bp.2014.054" target="_blank" >10.5507/bp.2014.054</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Hepatic arterial infusion in hepatocellular carcinoma: a single center experience.

  • Original language description

    AIM: The aim of the present study was to evaluate a single center experience with hepatic arterial infusion (HAI) in patients with hepatocellular carcinoma. METHODS: A retrospective analysis of 20 patients treated for hepatocellular carcinoma between 1994 and 2007. RESULTS: Most patients were treated with an HAI of doxorubicin and cisplatin combined with 5-fluorouracil and folinic acid. The response was not evaluable in the majority of patients, predominantly because of associated surgical procedure orbecause only one cycle of HAI was administered. The median progression-free survival was 7.7 months. The median survival of all patients was 12.2 months (5-year survival 5%). Serious adverse events were observed in 5 patients, and one patient died of liver failure in association with the administration of HAI. CONCLUSION: The data show the limited efficacy of HAI in patients with hepatocellular carcinoma.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FD - Oncology and haematology

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2015

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Biomedical Papers-Olomouc

  • ISSN

    1213-8118

  • e-ISSN

  • Volume of the periodical

    159

  • Issue of the periodical within the volume

    1

  • Country of publishing house

    CZ - CZECH REPUBLIC

  • Number of pages

    6

  • Pages from-to

    139-144

  • UT code for WoS article

  • EID of the result in the Scopus database